1. Home
  2. IMMP vs PWOD Comparison

IMMP vs PWOD Comparison

Compare IMMP & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • PWOD
  • Stock Information
  • Founded
  • IMMP 1987
  • PWOD 1934
  • Country
  • IMMP Australia
  • PWOD United States
  • Employees
  • IMMP N/A
  • PWOD N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • PWOD Major Banks
  • Sector
  • IMMP Health Care
  • PWOD Finance
  • Exchange
  • IMMP Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • IMMP 221.2M
  • PWOD 231.2M
  • IPO Year
  • IMMP N/A
  • PWOD N/A
  • Fundamental
  • Price
  • IMMP $1.72
  • PWOD $32.20
  • Analyst Decision
  • IMMP Buy
  • PWOD
  • Analyst Count
  • IMMP 1
  • PWOD 0
  • Target Price
  • IMMP $7.00
  • PWOD N/A
  • AVG Volume (30 Days)
  • IMMP 98.8K
  • PWOD 74.2K
  • Earning Date
  • IMMP 02-27-2025
  • PWOD 07-24-2025
  • Dividend Yield
  • IMMP N/A
  • PWOD 3.98%
  • EPS Growth
  • IMMP N/A
  • PWOD 28.19
  • EPS
  • IMMP N/A
  • PWOD 2.80
  • Revenue
  • IMMP $3,019,249.00
  • PWOD $74,314,000.00
  • Revenue This Year
  • IMMP $50.37
  • PWOD N/A
  • Revenue Next Year
  • IMMP N/A
  • PWOD N/A
  • P/E Ratio
  • IMMP N/A
  • PWOD $11.52
  • Revenue Growth
  • IMMP 24.11
  • PWOD 16.68
  • 52 Week Low
  • IMMP $1.32
  • PWOD $18.91
  • 52 Week High
  • IMMP $2.72
  • PWOD $34.56
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 50.07
  • PWOD 74.33
  • Support Level
  • IMMP $1.53
  • PWOD $29.61
  • Resistance Level
  • IMMP $1.71
  • PWOD $30.49
  • Average True Range (ATR)
  • IMMP 0.07
  • PWOD 0.63
  • MACD
  • IMMP 0.01
  • PWOD 0.29
  • Stochastic Oscillator
  • IMMP 72.41
  • PWOD 97.64

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: